Danaher (NYSE:DHR) Upgraded at DZ Bank

Danaher (NYSE:DHRGet Free Report) was upgraded by DZ Bank to a “strong-buy” rating in a report released on Tuesday,Zacks.com reports.

DHR has been the topic of a number of other reports. TD Cowen decreased their price objective on Danaher from $245.00 to $240.00 and set a “buy” rating on the stock in a report on Wednesday, April 22nd. Wolfe Research lowered Danaher from an “outperform” rating to a “peer perform” rating in a report on Monday. UBS Group decreased their price objective on Danaher from $270.00 to $250.00 and set a “buy” rating on the stock in a report on Wednesday, April 22nd. Guggenheim decreased their price objective on Danaher from $275.00 to $235.00 and set a “buy” rating on the stock in a report on Wednesday, April 22nd. Finally, Jefferies Financial Group reaffirmed a “buy” rating and issued a $245.00 price objective on shares of Danaher in a report on Tuesday, April 21st. One investment analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $235.14.

Read Our Latest Stock Report on DHR

Danaher Stock Up 1.3%

DHR stock opened at $178.40 on Tuesday. The company has a current ratio of 1.87, a quick ratio of 1.52 and a debt-to-equity ratio of 0.33. The firm has a market capitalization of $126.26 billion, a PE ratio of 34.51, a PEG ratio of 2.35 and a beta of 0.81. Danaher has a 1-year low of $160.93 and a 1-year high of $242.80. The business’s 50 day simple moving average is $181.40 and its 200 day simple moving average is $206.59.

Danaher (NYSE:DHRGet Free Report) last posted its earnings results on Monday, April 20th. The conglomerate reported $2.06 earnings per share for the quarter, topping analysts’ consensus estimates of $1.94 by $0.12. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The business had revenue of $5.95 billion for the quarter, compared to analyst estimates of $6 billion. During the same period in the previous year, the firm earned $1.88 EPS. The firm’s revenue was up 3.7% compared to the same quarter last year. As a group, research analysts anticipate that Danaher will post 8.43 EPS for the current year.

Institutional Trading of Danaher

A number of institutional investors have recently modified their holdings of DHR. Main Street Group LTD bought a new stake in shares of Danaher during the 1st quarter valued at $25,000. JPL Wealth Management LLC bought a new stake in shares of Danaher during the 3rd quarter worth $25,000. Elevated Capital Advisors LLC bought a new stake in shares of Danaher during the 4th quarter worth $26,000. WFA of San Diego LLC bought a new stake in shares of Danaher during the 2nd quarter worth $26,000. Finally, ANTIPODES PARTNERS Ltd bought a new stake in shares of Danaher during the 3rd quarter worth $27,000. 79.05% of the stock is currently owned by institutional investors.

Danaher Company Profile

(Get Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Recommended Stories

Analyst Recommendations for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.